We are live on
!
Find out more
SCA
Spearhead Capital Advisors Portfolio holdings
AUM
$92.3M
1-Year Est. Return
18.16%
This Fund
S&P 500
This Quarter
Est. Return
+8.65%
1 Year Est. Return
-18.16%
3 Year Est. Return
+25.24%
5 Year Est. Return
+54.04%
10 Year Est. Return
–
AUM
$524M
AUM Growth
+$55.6M
(+12%)
Cap. Flow
+$21.7M
Cap. Flow
% of AUM
4.14%
Top 10 Holdings %
Top 10 Hldgs %
32.65%
Holding
189
New
31
Increased
124
Reduced
25
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$5.1M |
| 2 |
Apple
AAPL
|
+$1.8M |
| 3 |
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
|
+$1.02M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$990K |
| 5 |
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
|
+$914K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$5.39M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$330K |
| 3 |
Vanguard Energy ETF
VDE
|
+$249K |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$218K |
| 5 |
Amazon
AMZN
|
+$180K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.7% |
| 2 | Healthcare | 11.74% |
| 3 | Consumer Staples | 10.79% |
| 4 | Communication Services | 9.31% |
| 5 | Financials | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
PTC
PTC
$15.8B
| $215K | 0.04% |
+2,594
| New | +$221K |
|
|
P
177
Everpure Inc
P
$25.7B
| $211K | 0.04% |
13,740
+1,071
| +8% | +$17.5K |
|
178
Neurocrine Biosciences
NBIX
$16.8B
| $210K | 0.04% |
2,186
+144
| +7% | +$16.7K |
|
179
Fortune Brands Innovations
FBIN
$5.88B
| $205K | 0.04% |
+2,772
| New | +$185K |
|
|
NEWR
180
DELISTED
New Relic, Inc.
NEWR
| $205K | 0.04% |
3,630
-687
| -16% | -$41.9K |
|
|
AYX
181
DELISTED
Alteryx Inc
AYX
| $204K | 0.04% |
1,800
+104
| +6% | +$14.2K |
|
182
Cooper Companies
COO
$14.1B
| $203K | 0.04% |
+2,404
| New | +$184K |
|
183
Illumina
ILMN
$31B
| $202K | 0.04% |
673
+30
| +5% | +$10.3K |
|
184
Cactus
WHD
$5.21B
| $195K | 0.04% |
+10,176
| New | +$221K |
|
|
ZUO
185
DELISTED
Zuora, Inc.
ZUO
| $182K | 0.03% |
17,608
+1,561
| +10% | +$18.1K |
|
|
186
Ionis Pharmaceuticals
IONS
$8.6B
| – | – |
-3,705
| Closed | -$218K |
|
|
187
Vanguard Energy ETF
VDE
$10.1B
| – | – |
-4,955
| Closed | -$249K |
|
|
188
ExxonMobil
XOM
$644B
| – | – |
-120,608
| Closed | -$5.39M |
|
|
PTLA
189
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| – | – |
-18,359
| Closed | -$330K |
|
Similar funds
AAM
AEPBI
MW
SC
NIM
WIM
LAM
EFEM
Spearhead Capital Advisors's Q3 2020 Portfolio in Review
As of Q3 2020, Spearhead Capital Advisors held 189 positions worth $524M, up 12% from $468M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Spearhead Capital Advisors deployed $21.7M of net new capital in Q3 2020, opening 31 new positions and adding to 124 existing holdings. Its largest new stake was Starbucks: 63,916 shares worth $5.49M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Amazon, an estimated $180K trimmed.
- Spearhead Capital Advisors's largest Q3 2020 buy was Starbucks: 63,916 shares worth $5.49M.
- Spearhead Capital Advisors added most to Apple in Q3 2020, an estimated $1.8M increase.
- Spearhead Capital Advisors's biggest Q3 2020 reduction was Amazon, cutting an estimated $180K.
- Spearhead Capital Advisors fully exited ExxonMobil in Q3 2020, selling an estimated $5.39M.
- Spearhead Capital Advisors's ten largest holdings make up 33% of its $524M portfolio in Q3 2020.
- Spearhead Capital Advisors opened 31 new positions and closed 4 in Q3 2020.
- Spearhead Capital Advisors's portfolio value rose 12% quarter-over-quarter to $524M.
Based on Spearhead Capital Advisors's 13F filing for Q3 2020, filed 16 Oct 2020.